4 completed, 1 recruiting, 1 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Recruiting 1, Terminated 1 |
Follow dalcetrapib: new trials by email Literature Review of dalcetrapib trials Research Report on dalcetrapib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Dalcetrapib, Placebo - Acute Coronary Syndrome | Phase 3 | Recruiting | DalCor Pharmaceuticals | 2000 | 2023-10-03 | 2026-06-22 |
| Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS dalcetrapib, Placebo - Acute Coronary Syndrome | Phase 3 | Completed | DalCor Pharmaceuticals | 6147 | 2016-04-01 | 2022-10-12 |
| A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease Background care, Placebo, dalcetrapib - Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) | Phase 3 | Completed | Hoffmann-La Roche | 2220 | 2012-01-01 | 2016-11-02 |
| A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE) dalcetrapib, placebo - Coronary Heart Disease | Phase 3 | Completed | Hoffmann-La Roche | 300 | 2011-03-01 | 2019-07-30 |
| A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease Dalcetrapib, Placebo - Cardiovascular Disease | Phase 3 | Terminated | Hoffmann-La Roche | 936 | 2010-01-01 | 2020-03-24 |
| A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome Dalcetrapib (RO4607381), Evidence-based medical care for Acute Coronary Syndrome, Placebo - Coronary Heart Disease | Phase 3 | Completed | Hoffmann-La Roche | 15871 | 2008-04-01 | 2020-01-03 |
Coronary Disease (3) · Acute Coronary Syndrome (2) · Cardiovascular Diseases (2) · Dyslipidemias (1) · Peripheral Arterial Disease (1)
Hoffmann-La Roche (4) · DalCor Pharmaceuticals (2)
United States (6) · Canada (5) · Czechia (4) · Netherlands (4) · Poland (4) · United Kingdom (4) · Australia (3) · Denmark (3) · France (3) · Germany (3) · Hungary (3) · Puerto Rico (3) · Spain (3) · Switzerland (3) · Argentina (2)
David Kallend, MBBS (1) · Donald M Black, MD (1)
PMID 25583994, PMID 27418594, PMID 19576325, PMID 19958854, PMID 20738227, PMID 22345126, PMID 23126252, PMID 26022813, PMID 28073769, PMID 29071331, PMID 31927126, PMID 32087417, PMID 32144166, PMID 34173811, PMID 35856777